EMERALD MUTUAL FUND ADVISERS TRUST

Mutual Fund

Position in TVTX — Travere Therapeutics, Inc.

CIK 1352895 Leola, PA

Position in TVTX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$58,629,283

+$30,552,353 QoQ

Shares Held

1,032,024

+9.2% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

2.13%

of 13F equity value

Holder Rank

#29

of 317 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EMERALD MUTUAL FUND ADVISERS TRUST holds $391,799,835 across 21 Biotechnology names. TVTX ranks #1 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc. This page	1,032,024	$58,629,283
2	CORT	Corcept Therapeutics Inc	464,902	$40,423,228
3	COGT	Cogent Biosciences, Inc.	1,031,378	$39,914,328
4	SYRE	Spyre Therapeutics, Inc.	401,271	$35,624,839
5	MIRM	Mirum Pharmaceuticals, Inc.	289,372	$33,876,780
6	MANE	Veradermics, Inc	209,924	$25,808,056
7	CYTK	Cytokinetics Inc	279,769	$23,833,521
8	TRVI	Trevi Therapeutics, Inc.	1,210,965	$22,584,497

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$58,629,283	1,032,024	+9.2%	Shares	Sole	2026-08-05
2026-03-31	$28,076,930	945,033	-0.4%	Shares	Sole	2026-05-04
2025-12-31	$36,240,618	948,459	-21.0%	Shares	Sole	2026-02-09
2025-09-30	$28,702,513	1,200,942	+5.2%	Shares	Sole	2025-10-30
2025-06-30	$16,893,134	1,141,428	+1.7%	Shares	Sole	2025-08-04
2025-03-31	$20,104,197	1,121,886	+1.8%	Shares	Sole	2025-05-01
2024-12-31	$19,192,903	1,101,774	-7.1%	Shares	Sole	2025-02-14
2024-09-30	$16,588,068	1,185,709	+26.0%	Shares	Sole	2024-10-29
2024-06-30	$7,737,198	941,265	-29.1%	Shares	Sole	2024-08-06
2024-03-31	$10,241,817	1,328,381	+73.7%	Shares	Sole	2024-05-08
2023-12-31	$6,873,780	764,603	0.0%	Shares	Sole	2024-02-05
2023-09-30	$6,835,550	764,603	+44.4%	Shares	Sole	2023-10-27
2023-06-30	$8,133,396	529,518	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.